IN8bio, Inc.IN8bio, Inc.IN8bio, Inc.

IN8bio, Inc.

No trades
See on Supercharts
Market capitalization
‪44.59 M‬USD
−1.01USD
‪−30.01 M‬USD
‪29.27 M‬
Beta (1Y)
0.88

About IN8bio, Inc.

CEO
William T. Ho
Website
Headquarters
New York
Employees (FY)
31
Founded
2016
FIGI
BBG00XX9K1M2
IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of INAB is 1.00 USD — it has decreased by 2.92% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange IN8bio, Inc. stocks are traded under the ticker INAB.
IN8bio, Inc. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
INAB stock is 4.52% volatile and has beta coefficient of 0.88. Check out the list of the most volatile stocks — is IN8bio, Inc. there?
One year price forecast for IN8bio, Inc. has a max estimate of 14.00 USD and a min estimate of 5.00 USD.
INAB earnings for the last quarter are −0.23 USD per share, whereas the estimation was −0.25 USD resulting in a 6.12% surprise. The estimated earnings for the next quarter are −0.15 USD per share. See more details about IN8bio, Inc. earnings.
Yes, you can track IN8bio, Inc. financials in yearly and quarterly reports right on TradingView.
INAB stock has fallen by 6.55% compared to the previous week, the month change is a 20.01% fall, over the last year IN8bio, Inc. has showed a 10.10% decrease.
INAB net income for the last quarter is ‪−7.60 M‬ USD, while the quarter before that showed ‪−7.17 M‬ USD of net income which accounts for −5.98% change. Track more IN8bio, Inc. financial stats to get the full picture.
Today IN8bio, Inc. has the market capitalization of ‪43.28 M‬, it has decreased by 1.79% over the last week.
No, INAB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, INAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IN8bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
INAB reached its all-time high on Aug 11, 2021 with the price of 10.32 USD, and its all-time low was 0.65 USD and was reached on Nov 22, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 31.00 employees. See our rating of the largest employees — is IN8bio, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IN8bio, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IN8bio, Inc. stock shows the sell signal. See more of IN8bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on IN8bio, Inc. future price: according to them, INAB price has a max estimate of 14.00 USD and a min estimate of 5.00 USD. Read a more detailed IN8bio, Inc. forecast: see what analysts think of IN8bio, Inc. and suggest that you do with its stocks.